DOVATO is designed differently, helping you stay undetectable* with fewer medicines in 1 pill
What makes DOVATO different?
DOVATO is a once-a-day complete treatment that delivers powerful results† and is designed differently, with fewer medicines. Take DOVATO exactly as directed by your healthcare provider.
Results may vary.
*Undetectable means the amount of HIV in the blood is below the level that can be measured by a lab test.
†Based on data from the GEMINI 1 & 2 studies (patients new to treatment) and TANGO study (patients replacing their current HIV treatment). DOVATO was compared with a regimen containing either 3 or 4 medicines, measuring either the percentage of patients with an undetectable viral load (<50 copies per mL) or the percentage of patients without an undetectable viral load (≥50 copies per mL).
How do I take DOVATO?
Four sheets hold 7 pills each, and one sheet holds 2 pills, for 30 pills total per pack. Each sheet in a pack is 79 mm x 55 mm.
What do the studies say?
If you are considering switching treatment or are new to treatment, DOVATO is clinically proven to be as effective as a regimen containing 3 or 4 medicines. See details below.
DOVATO was Proven
to help people already on treatment stay undetectable as effectively as an HIV regimen containing 3 or 4 medicines†
Less than 1% had a detectable viral load (50 or more copies per mL) with DOVATO or a 3- or 4-drug regimen† at 1 year. Similar results were seen at 3 years.
0 Resistance
Over 3 years of clinical trials, no patients who switched to DOVATO developed HIV resistance
Results showed that DOVATO works as well as a 3- or 4-drug regimen in diverse groups of adults, regardless of age, sex, race, or CD4 T-cell count.
Side Effects
In this study, 15% of patients taking DOVATO versus 5% taking a 3- or 4-drug regimen† experienced side effects over a 3-year period. The majority of side effects were mild in severity.
The most common side effects were:
Taking DOVATO: weight gain (3%), trouble sleeping (2%), nausea (1%), diarrhea (1%), and anxiety (1%).
- Taking a 3- or 4-drug regimen†: weight gain (2%), nausea (<1%), diarrhea (<1%), and anxiety (<1%).
†Tenofovir alafenamide (TAF)–based 3- or 4-drug regimen.
Proven effective in people new to HIV treatment
In two combined studies, DOVATO was proven to help people new to treatment reach and stay undetectable (less than 50 copies per mL) as effectively as a regimen containing 3 medicines.‡
Side Effects
Across the two combined studies, 20% of patients taking DOVATO versus 27% taking a 3-drug regimen‡ experienced side effects over a 3-year period.
The most common side effects were:
- Taking DOVATO: headache (3%), nausea (2%), diarrhea (2%), trouble sleeping (2%), tiredness (2%), anxiety (2%), and dizziness (1%).
- Taking a 3-drug regimen‡: headache (4%), nausea (6%), diarrhea (3%), trouble sleeping (3%), tiredness (2%), anxiety (<1%), and dizziness (2%).
‡Dolutegravir + tenofovir disoproxil fumarate/emtricitabine.
PMUS-DLLWCNT240019